Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Sulfo-Cy3 NHS Ester for Vascular Assays

    2026-08-12

    Sulfo-Cy3 NHS Ester for Vascular Assays

    Mechanistic vascular biology often depends on following proteins, lipoprotein-associated material, or antibody probes through complex cell systems. The challenge is to generate a bright, soluble conjugate without destabilizing the biological carrier. Sulfo-Cy3 NHS ester addresses that need as a sulfonated, hydrophilic fluorescent dye for labeling primary amines on proteins and peptides.

    Its NHS ester reacts with lysine side chains and N-terminal amines, while its sulfonate groups support aqueous handling and help reduce dye-dye interactions. The product information reports excitation and emission maxima of 563 and 584 nm, respectively, together with a molar extinction coefficient of 162,000 M−1cm−1 and a quantum yield of 0.1. These specifications make it suitable for confocal microscopy, plate-based uptake assays, flow cytometry, and biochemical fractionation, provided that free dye is removed and the labeling ratio is controlled.

    Setup and Principle Overview

    The central design principle is simple: expose a purified amine-containing biomolecule to a freshly prepared NHS ester under mildly basic, amine-free conditions, then separate the conjugate from unreacted fluorophore. Phosphate or bicarbonate buffers are generally preferable during the reaction. Tris, glycine, ammonium salts, and other primary-amine-containing reagents should be excluded until the reaction is complete because they can consume the activated ester.

    For vascular studies, the labeled species may be recombinant AIBP, an HDL-associated protein, an anti-CXCR4 or anti-LRP2 antibody, or another defined protein reagent. Sulfo-Cy3 NHS ester does not directly label miR-223, which is an RNA cargo in the reference mechanism. Therefore, fluorescence of a labeled HDL or protein component should be interpreted as carrier or protein trafficking, not as proof that the RNA cargo reached the same compartment. Use RNA-specific measurements and pathway controls when the biological question concerns miRNA delivery.

    The hydrophilic format is especially useful for proteins with limited solubility or a tendency to denature when organic cosolvents are introduced. The product information lists water solubility of at least 10.24 mg/ml, with higher stated solubility in ethanol and lower but useful solubility in DMSO. In practice, an aqueous working solution prepared immediately before use is often the most compatible option for sensitive proteins. The supplier, APExBIO, recommends dark storage at −20°C for the solid and discourages long-term storage of solutions.

    Key Innovation from the Reference Study

    The Zhu et al. reference study identified a two-phase control system for collateral circulation in ischemic tissue. The authors linked elevated AIBP with disease context, showed that AIBP deletion expanded CXCR4-positive capillary endothelial cells with stemlike and proliferative characteristics, and found that these cells could remodel into functional collaterals. Mechanistically, AIBP interacted with LRP2 to promote endothelial uptake of HDL-associated miR-223, which repressed CXCR4. Blocking or disrupting this axis restored CXCR4 signaling and supported collateral growth.

    The reported strategy combined plasma profiling, ischemic murine muscle analysis, genetic manipulation, endothelial-cell characterization, and CXCR4 inhibition. The paper did not establish Sulfo-Cy3 NHS ester as part of its published experimental method. Its value here is as a practical assay-enabling translation: the pathway creates several trafficking questions that require a robust fluorescent label.

    • To study carrier uptake, label a protein component of purified HDL or a defined HDL-binding reagent, then quantify cell-associated signal after washing.
    • To examine receptor localization, label an antibody or recombinant ligand while preserving an independently measured binding function.
    • To distinguish endothelial uptake from nonspecific adhesion, compare labeled material in control and LRP2- or AIBP-perturbed conditions, alongside temperature and excess-unlabeled-material controls.
    • To connect imaging with mechanism, pair Cy3 fluorescence with CXCR4 abundance, endothelial identity, and functional collateralization readouts rather than treating fluorescence alone as evidence of pathway activation.

    This is the key assay choice: use the dye to resolve where a protein or carrier goes, while using orthogonal molecular measurements to determine what that traffic does biologically.

    Step-by-Step Workflow for Protein and Carrier Labeling

    1. Define the labeling objective and controls

    Decide whether the experiment measures surface binding, internalization, intracellular colocalization, or bulk recovery after fractionation. Include an unlabeled biological control, a dye-only control, and a labeled-material control processed without cells. For live-cell work, establish whether the conjugate changes viability, proliferation, or receptor binding before collecting mechanistic data.

    2. Prepare the biomolecule

    Exchange the protein into a neutral-to-mildly basic buffer without primary amines. Remove free carrier proteins, reducing agents that interfere with downstream chemistry, and excess salts when they cause precipitation. Record protein concentration by an independent assay because absorbance from Cy3 can bias protein quantification after labeling.

    3. Perform the reaction

    Add the freshly prepared dye gradually to the protein while mixing gently. A low-to-moderate dye-to-protein molar ratio is a useful starting point for antibodies and fragile proteins; higher ratios can increase brightness but also promote steric interference, altered receptor binding, and self-quenching. For HDL or multicomponent preparations, characterize the labeled fraction rather than assuming every particle carries the same number of fluorophores.

    4. Quench and purify

    After the reaction, quench residual NHS ester with a compatible primary-amine reagent and separate the conjugate from free Sulfo-Cy3. Size-exclusion chromatography is particularly useful for preserving soft protein assemblies. Spin filtration can work for monodisperse proteins, but repeated concentration and dilution may damage weak complexes. Retain the flow-through and purified fractions so that free-dye carryover can be measured.

    Protocol Parameters

    • Protein preparation: Use 0.5–2 mg/ml protein in 100–500 µl of phosphate or bicarbonate buffer at pH 7.8–8.5; exclude Tris and glycine during the reaction.
    • Dye preparation: Prepare a fresh 1 mM aqueous Sulfo-Cy3 solution and use it within 10–20 minutes; add a 5–20-fold molar excess over protein as an optimization range.
    • Conjugation: Incubate the mixture for 20–60 minutes at 20–25°C with gentle agitation and protect the tube from direct light.
    • Quenching: Add Tris to 50 mM only after labeling, then incubate for 10 minutes at 20–25°C before purification.
    • Buffer exchange: For a spin-filter workflow, perform 3 exchanges using 500 µl of assay buffer per cycle, selecting a membrane cutoff appropriate for the labeled biomolecule.
    • Storage: Keep the dry product at −20°C in the dark and prepare only the solution volume needed for the same working session; follow the product information for stated storage and transport limits.

    These are practical starting conditions, not universal optima. The best degree of labeling depends on protein size, accessible amines, oligomeric state, and whether the conjugate must retain receptor activity.

    Advanced Applications and Comparative Advantages

    In a cell-uptake assay, a labeled HDL-associated protein can provide a direct kinetic readout of binding and internalization. A pulse-chase design can separate initial surface association from later intracellular accumulation. Imaging at the reported 563-nm excitation and 584-nm emission maxima can be performed with standard Cy3-compatible filter sets, but detector settings should be established using the labeled sample and an unlabeled autofluorescence control.

    For endothelial models, a useful workflow is to label the trafficking reagent, expose cells under normoxic and ischemia-mimicking conditions, wash rigorously, and quantify cell-associated fluorescence per viable cell. Confocal z-stacks or acid-stripping controls can help distinguish internalized material from surface-bound conjugate. In parallel, measure CXCR4 and endothelial-state markers so the experiment retains the mechanistic logic of the AIBP-LRP2-HDL-miR-223 axis.

    The dye is also compatible with a fluorescent probe for cell biology applications where water compatibility matters more than maximal quantum yield. Compared with a non-sulfonated Cy3 NHS ester, the sulfonated structure can simplify labeling of hydrophobic or aggregation-prone proteins by avoiding an organic cosolvent during conjugation. Its high extinction coefficient supports sensitive detection, although the stated quantum yield of 0.1 means that brightness must still be assessed in the actual buffer and instrument.

    For QD-dye conjugates synthesis, the NHS group can modify amine-presenting quantum-dot coatings or linker proteins. This is an extension rather than a direct test of the vascular study, so confirm that the coating remains colloidally stable and that the dye does not alter particle uptake. The existing guide Sulfo-Cy3 NHS Ester: Reliable Protein Labeling for Cell Assays complements this workflow with assay-oriented labeling considerations, while the article on advanced protein labeling for stemlike capillary expansion extends the discussion toward stemlike endothelial biology and the reference mechanism.

    Troubleshooting and Optimization Tips

    Weak or inconsistent fluorescence

    Check whether the dye was exposed to moisture, light, or an unsuitable pH before addition. NHS esters hydrolyze in aqueous solution, so prepare small fresh aliquots rather than storing a working solution. Confirm that the protein actually contains accessible primary amines and that purification did not remove the labeled fraction. Measure both protein and dye absorbance after purification to estimate the degree of labeling instead of relying on fluorescence intensity alone.

    High background or apparent uptake in controls

    Free dye is a common cause of diffuse cellular signal. Extend size-exclusion separation, add an additional buffer exchange, or analyze the final preparation by chromatography. Include a dye-only control exposed to the complete workflow. If signal remains at the plasma membrane after washing, reduce the probe concentration, increase wash stringency, or add a cold competition control with excess unlabeled material.

    Protein precipitation or loss of activity

    Excess fluorophore, prolonged incubation, high protein concentration, and local overmixing can destabilize sensitive conjugates. Repeat the reaction with a lower dye-to-protein ratio and a shorter incubation. Maintain the protein in its validated stabilizing buffer where possible, then adjust only the components that react with NHS ester. For low-solubility proteins, the water-soluble sulfonated format may be preferable, but it does not eliminate the need for low-binding tubes and gradual reagent addition.

    Signal is bright but biology is altered

    Overlabeling can block a receptor-binding surface or change the charge and hydrodynamic behavior of a carrier. Compare labeled and unlabeled material in a functional binding assay before interpreting uptake. If the conjugate loses activity, reduce the molar excess, shorten the reaction, or label a separate reporter antibody rather than the functional ligand itself.

    Photobleaching and spectral interference

    Limit illumination, use neutral-density settings during setup, and collect images with consistent exposure. Cy3-compatible channels can overlap with other orange-red fluorophores, so validate compensation and bleed-through with single-color controls. For plate assays, calculate signal relative to cell number and include a blank well containing buffer and dye-free cells.

    Future Outlook

    The reference study supports a more informative future for vascular remodeling assays: combine spatial tracking of protein or HDL-associated material with independent measurements of the CXCR4-centered endothelial response. Sulfo-Cy3 NHS ester can contribute the trafficking layer, particularly in live-cell imaging, pulse-chase experiments, and flow-based uptake measurements. The strongest studies will preserve the distinction between labeled-carrier localization and miR-223 function, validate conjugate activity, and report labeling ratios, purification performance, and photometric controls. Used this way, a hydrophilic fluorescent dye becomes more than a visual tag: it is a practical bridge between molecular trafficking and the cellular remodeling phenotypes described in ischemic collateral circulation.